These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis. Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149 [TBL] [Abstract][Full Text] [Related]
9. Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa. Sudarshan MK; Madhusudana SN; Mahendra BJ; Narayana DH; Giri MS; Muhamuda K; Ravish HS; Venkatesh GM Natl Med J India; 2006; 19(4):192-4. PubMed ID: 17100105 [TBL] [Abstract][Full Text] [Related]
10. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization. Shiota S; Khawplod P; Ahmed K; Mifune K; Nishizono A Vaccine; 2008 Nov; 26(50):6441-4. PubMed ID: 18804510 [TBL] [Abstract][Full Text] [Related]
11. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine. Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642 [TBL] [Abstract][Full Text] [Related]
14. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population. Sehgal S; Bhattacharya D; Bhardwaj M J Commun Dis; 1995 Mar; 27(1):36-43. PubMed ID: 7636151 [TBL] [Abstract][Full Text] [Related]
15. Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus. Sirikwin S; Likanonsakul S; Waradejwinyoo S; Pattamadilok S; Kumperasart S; Chaovavanich A; Manatsathit S; Malerczyk C; Wasi C Vaccine; 2009 Jul; 27(32):4350-4. PubMed ID: 19487057 [TBL] [Abstract][Full Text] [Related]
16. Preventing rabies with the Verorab vaccine: 1985-2005 Twenty years of clinical experience. Toovey S Travel Med Infect Dis; 2007 Nov; 5(6):327-48. PubMed ID: 17983973 [TBL] [Abstract][Full Text] [Related]
17. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Khawplod P; Wilde H; Sirikwin S; Benjawongkulchai M; Limusanno S; Jaijaroensab W; Chiraguna N; Supich C; Wangroongsarb Y; Sitprija V Vaccine; 2006 Apr; 24(16):3084-6. PubMed ID: 16494972 [TBL] [Abstract][Full Text] [Related]
18. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults. Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety study of Indirab: a Vero cell based chromatographically purified human rabies vaccine. Sampath G; Madhusudana SN; Sudarshan MK; Ashwathnarayana DH; Mahendra BJ; Ullas TP; Mohan K; Madhusudhan SK; Ravish HS Vaccine; 2010 May; 28(24):4086-90. PubMed ID: 20403351 [TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine. Deshpande AK; Londhe VA; Akarte S; Briggs D J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]